Screener
Vor Biopharma VOR Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Vor Biopharma’s reported figures.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
FAQ
- What is Vor Biopharma's enterprise value?
- Vor Biopharma (VOR) reported enterprise value of $704.51M in Q1 2026.
- How has Vor Biopharma's enterprise value changed year-over-year?
- Vor Biopharma's enterprise value increased by 901.9% year-over-year, from $70.32M to $704.51M.
- What is the long-term trend for Vor Biopharma's enterprise value?
- Over 4 years (2021 to 2025), Vor Biopharma's enterprise value has grown at a -24.6% compound annual growth rate (CAGR), from $331.56M to -$106.89M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Vor Biopharma's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude